Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04817865

Comparison of Pre-procedural PCR and Culture-based UTI Assessment Prior to Intravesical Botox Injection

A Retrospective Comparison of Pre-procedural PCR and Culture-based UTI Assessment Prior to Intravesical Botox for the Treatment of Neurogenic or Non-neurogenic Overactive Bladder

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Pathnostics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is a retrospective record review to determine whether a novel multiplex PCR assay can be utilized as a screening method for UTI in patients receiving Botox injection to treat overactive bladder (OAB).

Detailed description

The novel multiplex real-time PCR assay with mixed floral antibiotic resistance profiling offers a higher degree of sensitivity and specificity than conventional culture methods in the identification of UTI pathogens as determined by a previous prospective comparison study. This is a retrospective record review comparing PCR and culture-based assessments for UTI in patients receiving Botox injection to treat overactive bladder (OAB). Investigators aim to determine whether M-PCR/P-AST can be utilized as a screening method for UTI in these patients and whether whether antibiotic prophylaxis, peri-procedural antibiotics, and post-injection antibiotic therapy based on patients' pre-procedural M-PCR/P-AST results in improved response to Botox injection compared to standard of care. The attributes and advantages of PCR testing over the use of traditional urine cultures, and the potential identification of polymicrobial infections with complicated resistance sharing mechanisms, may significantly improve patient care.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMultiplex-PCR with Pooled Antibiotic Susceptibility Testing (M-PCR/P-AST)M-PCR/P-AST is a dual assessment test that detects pathogenic DNA commonly associated with urinary tract infections and identifies their genotypic and phenotypic antibiotic resistance.
DIAGNOSTIC_TESTUrine CultureA traditional clinical UTI evaluation consisting of non-molecular standard urine culture (SUC) and sensitivity testing methods.

Timeline

Start date
2020-08-15
Primary completion
2021-02-10
Completion
2023-07-31
First posted
2021-03-26
Last updated
2023-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04817865. Inclusion in this directory is not an endorsement.